ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.790,35
0,59%
S&P 500
5.214,08
0,51%
Dow Jones
39.387,76
0,85%
Euro vs US Dollar
1,07818
0,00%
Bitcoin
63.016,60
-0,05%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Alseres Pharmaceuticals Inc (CE) (ALSE)

  7. Alseres Pharmaceuticals Inc (CE) (ALSE) News

ALSE

Alseres Pharmaceuticals (CE) (ALSE)

Alseres Pharmaceuticals Inc (CE)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:ALSE
DatumZeitQuelleÜberschriftSymbolFirma
21/11/201422h10Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
18/11/201421h09Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
14/08/201414h09Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
23/05/201419h04Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
16/05/201415h46Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
10/04/201414h52Edgar (US Regulatory)Annual Report (10-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
31/03/201423h00Edgar (US Regulatory)Quarterly Schedule of Portfolio Holdings of Registered Management Investment Company (n-q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
31/03/201423h00Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
31/07/201314h29Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
17/05/201320h47Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
16/05/201320h44Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
01/04/201319h23Edgar (US Regulatory)Annual Report (10-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
21/02/201321h05Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
07/02/201314h03Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
28/01/201320h40Edgar (US Regulatory)Definitive Materials Filed by Investment Companies. (497)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
28/01/201320h40Edgar (US Regulatory)Annual Report (management Company) (nsar-b)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
28/01/201320h37Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
28/01/201318h40Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
08/01/201316h21Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
08/01/201316h21Edgar (US Regulatory)Current report filing (8-K)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
14/11/201212h08Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
14/11/201212h08Edgar (US Regulatory)Quarterly Report (10-Q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
13/08/201212h16Edgar (US Regulatory)Quarterly Report (10-Q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
23/07/201212h02Edgar (US Regulatory)Current report filing (8-K)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
02/07/201214h30Edgar (US Regulatory)Current report filing (8-K)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
13/06/201216h06Edgar (US Regulatory)Current report filing (8-K)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
11/05/201221h18Edgar (US Regulatory)Quarterly Report (10-Q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
08/05/201222h12Edgar (US Regulatory)Current report filing (8-K)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
29/03/201222h50Edgar (US Regulatory)Annual Report (10-K)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
19/03/201220h50Edgar (US Regulatory)Current report filing (8-K)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
 Showing the most relevant articles for your search:USOTC:ALSE

Kürzlich von Ihnen besucht

NYSE
MRK
Merck
USOTC
RHHBY
Roche (QX)
DBI
DAX
DAX
USOTC
DTEGY
Deutsche Telekom (QX)
TG
MBG
MercedesBenz
COIN
SOLUSD
Solana
AMEX
XLF
Financial Select Sector
TG
NOV
Novo Nordisk
FX
EURUSD
Euro vs US Dollar
TG
TUI1
Tui
TG
CBK
Commerzbank
TG
D7G
Nel ASA
USOTC
BNPQY
BNP Paribas (QX)
COIN
BTCUSD
Bitcoin
COIN
ETHUSD
Ethereum
USOTC
BASFY
BASF (QX)
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten